Babel Health, Inc.
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
Babel Health, Inc. - overview
Established
2015
Location
Pittsburgh, PA, US
Primary Industry
Software
About
Babel Health, Inc. is a healthcare technology company that develops solutions aimed at optimizing encounter data submissions for government-sponsored programs, ensuring compliance and improving operational efficiency for healthcare organizations. Founded in 2015 and headquartered in Pittsburgh, US, Babel Health, Inc. specializes in healthcare technology solutions.
The company has successfully raised USD 5. 00 mn in Series A funding as of April 25, 2019, co-led by Magarac Venture Partners. Mark Tobias is the founder, while Robert Dunn serves as the CEO. Babel Health, Inc.
offers a suite of healthcare technology solutions centered around its flagship product, Veradigm Comprehensive Submissions. This platform enables healthcare providers, payers, and life science organizations to manage encounter data submissions efficiently, supporting programs like Medicare Advantage and Managed Medicaid. The system features real-time data access, error correction, and lifecycle tracking, addressing the complexities of health data management. Babel Health, Inc.
generates revenue through subscription-based models and partnerships with healthcare organizations, primarily utilizing its Comprehensive Submissions platform. Clients subscribe to various packages for core services, including risk adjustment analytics and data exchange capabilities, fostering long-term partnerships with pricing tailored to the services used. Babel Health, Inc. plans to leverage its recent Series A funding of USD 5.
00 mn to enhance its product offerings and expand its market reach. The company is focused on developing new functionalities for its platform and aims to enter additional geographic markets by 2022. The funding will support these initiatives, reinforcing Babel's commitment to optimizing healthcare data management.
Current Investors
Bilgola Capital, Magarac Venture Partners
Primary Industry
Software
Sub Industries
Analytics & Performance Software
Website
www.babelhealth.com
Verticals
Cloud Computing
Company Stage
Series A
Total Amount Raised
Subscriber access only
Babel Health, Inc. - employee data
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.